Loading...
OTCM
DYBTY
Market cap3.96bUSD
, Last price  
USD
Name

Duality Biotherapeutics Inc

Chart & performance

D1W1MN
OTCM:DYBTY chart
P/E
—
P/S
—
EPS
Div yield, %
—
Shrs. gr., 5y
—
Rev. gr., 5y
%
Revenues
Net income
CFO

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Key people

Zhongyuan Zhu
Executive Chairman of the Board, Founder, Chief Executive Officer · since 2024
Haiqing Hua
Senior Vice President, Head - Drug Discovery · since 2024
Yang Qiu
Chief Scientific Officer · since 2022
Ruiyin Chu
Vice President - Translational Medicine · since 2023
Rong Shi
Vice President - Development Science · since 2022
Xin Yu
Vice President, Head - Regulatory Affairs · since 2022
Lan Zhou
Vice President - Commercial Strategy · since 2024
Wen Si
Executive Director, Director of Human Resources · since 2024
Shaoren Zhang
Vice President - Finance, Executive Director · since 2024
Wei Gu
Chief Medical Officer · since 2022
Hua Mu
Global Chief Medical Officer · since 2025
Xin Wang
Chief Business Officer · since 2025
Wing Man Tsang
Joint Company Secretary · since 2024
Jiali Yuan
Joint Company Secretary, Head - Legal and Compliance
Zhiyang Cai
Non-Executive Director · since 2024
Tao Yu
Non-Executive Director · since 2024
Shuyin Chuai
Independent Non-Executive Director · since 2024
Fengyong Gao
Independent Non-Executive Director · since 2024
Dong Xie
Independent Non-Executive Director · since 2024
IPO date
Apr 15, 2025
Employees
Domiciled in
CN
Incorporated in
KY
Legal address
C/O Harneys Fiduciary (Cayman) Limited
P. O. Box 10240
4th Floor, Harbour Place
103 South Church Street, Grand Cayman
George Town KY1-1002
KY
Headquarters
11F, Building A, No 868 YingHua Road
Pudong New District
Shanghai
China
Shanghai, SH 201204
CN
Address
A幢11楼
樱花路868号
浦东新区
上海市
上海市, SH 201204
CN
Trading name
映恩生物

Valuation

No data to show